143 related articles for article (PubMed ID: 18687986)
1. The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment.
van Maldegem F; van Dijk R; Wormhoudt TA; Kluin PM; Willemze R; Cerroni L; van Noesel CJ; Bende RJ
Blood; 2008 Oct; 112(8):3355-61. PubMed ID: 18687986
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment.
van Maldegem F; Wormhoudt TA; Mulder MM; Oud ME; Schilder-Tol E; Musler AR; Aten J; Saeed P; Kersten MJ; Pals ST; van Noesel CJ; Bende RJ
Leukemia; 2012 Jul; 26(7):1647-53. PubMed ID: 22382892
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.
Edinger JT; Kant JA; Swerdlow SH
Am J Surg Pathol; 2010 Dec; 34(12):1830-41. PubMed ID: 21107089
[TBL] [Abstract][Full Text] [Related]
4. IRTA1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression.
Carlsen ED; Bhavsar S; Cook JR; Swerdlow SH
J Cutan Pathol; 2022 Jan; 49(1):55-60. PubMed ID: 34309899
[TBL] [Abstract][Full Text] [Related]
5. Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.
Carlsen ED; Swerdlow SH; Cook JR; Gibson SE
Am J Surg Pathol; 2019 Oct; 43(10):1403-1412. PubMed ID: 31464711
[TBL] [Abstract][Full Text] [Related]
6. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.
Bende RJ; Aarts WM; Riedl RG; de Jong D; Pals ST; van Noesel CJ
J Exp Med; 2005 Apr; 201(8):1229-41. PubMed ID: 15837810
[TBL] [Abstract][Full Text] [Related]
7. Primary Nondural Central Nervous System Marginal ZoneB-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type Mimicking CNS Inflammatory Diseases.
Sugita Y; Hashimoto G; Fukuda K; Takahashi K; Shioga T; Furuta T; Arakawa F; Ohshima K; Nakamura H; Miyata H; Watanabe M; Kakita A
J Neuropathol Exp Neurol; 2021 Sep; 80(8):789-799. PubMed ID: 34383910
[TBL] [Abstract][Full Text] [Related]
8. Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.
Bende RJ; Janssen J; Beentjes A; Wormhoudt TAM; Wagner K; Haacke EA; Kroese FGM; Guikema JEJ; van Noesel CJM
Arthritis Rheumatol; 2020 Aug; 72(8):1330-1340. PubMed ID: 32182401
[TBL] [Abstract][Full Text] [Related]
9. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas.
Brynes RK; Almaguer PD; Leathery KE; McCourty A; Arber DA; Medeiros LJ; Nathwani BN
Mod Pathol; 1996 Oct; 9(10):995-1000. PubMed ID: 8902837
[TBL] [Abstract][Full Text] [Related]
10. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
Bende RJ; Slot LM; Hoogeboom R; Wormhoudt TA; Adeoye AO; Guikema JE; van Noesel CJ
Arthritis Rheumatol; 2015 Apr; 67(4):1074-83. PubMed ID: 25546553
[TBL] [Abstract][Full Text] [Related]
11. How I Diagnose Primary Cutaneous Marginal Zone Lymphoma.
Gibson SE; Swerdlow SH
Am J Clin Pathol; 2020 Sep; 154(4):428-449. PubMed ID: 32808967
[TBL] [Abstract][Full Text] [Related]
12. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation.
Ballesteros E; Osborne BM; Matsushima AY
Am J Surg Pathol; 1998 Feb; 22(2):201-7. PubMed ID: 9500221
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
14. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins.
Craig VJ; Arnold I; Gerke C; Huynh MQ; Wündisch T; Neubauer A; Renner C; Falkow S; Müller A
Blood; 2010 Jan; 115(3):581-91. PubMed ID: 19965661
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism.
Ohshima K; Suefuji H; Karube K; Hamasaki M; Hatano B; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kikuchi M
Leuk Lymphoma; 2003 Feb; 44(2):329-36. PubMed ID: 12688353
[TBL] [Abstract][Full Text] [Related]
16. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type.
Carbone A; Gloghini A; Ferlito A
Ann Otol Rhinol Laryngol; 2000 Dec; 109(12 Pt 1):1170-5. PubMed ID: 11130833
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression.
Brenner I; Roth S; Puppe B; Wobser M; Rosenwald A; Geissinger E
Mod Pathol; 2013 Dec; 26(12):1568-76. PubMed ID: 23765244
[TBL] [Abstract][Full Text] [Related]
18. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
19. Analysis of immunoglobulin V genes suggests cutaneous marginal zone B-cell lymphomas recognise similar antigens.
Bahler DW; Kim BK; Gao A; Swerdlow SH
Br J Haematol; 2006 Mar; 132(5):571-5. PubMed ID: 16445829
[TBL] [Abstract][Full Text] [Related]
20. Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations.
Xochelli A; Bikos V; Polychronidou E; Galigalidou C; Agathangelidis A; Charlotte F; Moschonas P; Davis Z; Colombo M; Roumelioti M; Sutton LA; Groenen P; van den Brand M; Boudjoghra M; Algara P; Traverse-Glehen A; Ferrer A; Stalika E; Karypidou M; Kanellis G; Kalpadakis C; Mollejo M; Pangalis G; Vlamos P; Amini RM; Pospisilova S; Gonzalez D; Ponzoni M; Anagnostopoulos A; Giudicelli V; Lefranc MP; Espinet B; Panagiotidis P; Piris MA; Du MQ; Rosenquist R; Papadaki T; Belessi C; Ferrarini M; Oscier D; Tzovaras D; Ghia P; Davi F; Hadzidimitriou A; Stamatopoulos K
J Pathol; 2019 Apr; 247(4):416-421. PubMed ID: 30484876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
